PubMed

Evaluando la Robustez Clínica de Empresas de Salud Digital: Análisis Observacional Transversal.

PMID: 35723914 · 2022-06-20

S, e, a, n, , D, a, y, ;, , V, e, e, r, a, j, , S, h, a, h, ;, , S, a, r, i, , K, a, g, a, n, o, f, f, ;, , S, h, a, n, n, o, n, , P, o, w, e, l, s, o, n, ;, , S, i, m, o, n, , C, , M, a, t, h, e, w, s

RevistaJournal of medical Internet research

Año2022-06-20

PMID35723914

Resumen

The digital health sector has experienced rapid growth over the past decade. However, health care technology stakeholders lack a comprehensive understanding of clinical robustness and claims across the industry. This analysis aimed to examine the clinical robustness and public claims made by digital health companies. A cross-sectional observational analysis was conducted using company data from the Rock Health Digital Health Venture Funding Database, the US Food and Drug Administration, and the

Fuente oficial

Ver en PubMed →

Datos obtenidos de PubMed / NCBI. Para consultar el texto completo y la información más reciente, remítase siempre al registro oficial.